Your Article Summary
See Latest ArticlesAggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization
Arteriosclerosis, Thrombosis, and Vascular Biology, 06/29/09
Grosheva I et al. – Results describe a novel process during aggregated LDL (agLDL)–macrophage interactions in which local release of free cholesterol causes local actin polymerization, promoting a pathological positive feedback loop for increased catabolism of agLDL and eventual foam cell formation.
Methods- Study of whether engagement of agLDL by macrophages leads to local increases in free cholesterol levels and whether these increases in free cholesterol regulate signals that control cellular actin
- AgLDL resides for prolonged periods in surface-connected compartments
- agLDL remains extracellular
- An increase in free cholesterol occurs at sites of contact between agLDL and cells due to hydrolysis of agLDL-derived cholesteryl ester
- Increased free cholesterol causes enhanced actin polymerization around agLDL
- Inhibition of cholesteryl ester hydrolysis results in decreased actin polymerization
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09
Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Arthritis Care and Research , 11/03/09
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Cardiovascular Drugs and Therapy, 11/03/09